Objective To analyze the epidemiological characteristics of methicillin resistant Staphylococcus aureus (MRSA) in nosocomial infection with pulsed field gel electrophoresis (PFGE) and PCR SCCmec typing.Methods Forty strains of MRSA collected from Tianjin Nankai Hospital between January, 2007 and December, 2008 were performed antimicrobial susceptibility analysis, PFGE and SCCmec genotyping.Results Antimicrobial susceptibility patterns of 40 strains of MRSA were highly similar, isolates were classified into AE five types by PFGE typing,type A, B, C, D, E were 21, 8, 4, 6, 1 strains respectively; SCCmec typing showed that 1 strain was SCCmecⅠ,33 were SCCmecⅢ, 1 was SCCmecⅣ,and 5 were SCCmecV. Sporadic infection of MRSA occurred in the hospital during the studied period. Conclusion Epidemiological analysis indicates that PFGE typing can identify the genetic relationship between isolates, SCCmec typing can suggest whether MRSA isolates are hospitalacquired .Combination of two genotyping methods can show characteristics of epidemic strains, and provide reference for nosocomial infection surveillance.
ObjectiveTo investigate an outbreak of nosocomial infection(NI) with multidrugresistant(MDR) Acinetobacter baumannii (A.baumannii) in an intensive care unit (ICU). MethodsNine strains isolated from patients and 24 strains isolated from ICU environment during NI outbreak with MDR A.baumannii were typed by repetitive extragenic palindromicpolymerase chain reaction (repPCR) and antimicrobial susceptibility was tested by KirbyBauer method. ResultsNine strains isolated from patients were divided into 4 genotypes by repPCR, type E1 and E2 had 4 and 3 strains respectively, both type E3 and E4 had 1 strain. 24 strains of A .baumannii were isolated from the environmental samples, 17 of which belonged to type E1. Antimicrobial sensitivity test results showed that all clinical isolates and 19 environmental isolates were multidrugresistant strains.ConclusionThe MDR A.baumannii outbreak in ICU was caused by transmission of E1 and E2 genotype A.baumannii among patients, and environment was also contaminated.
ObjectiveTo study the distribution and change of microbial population of clinical isolated bacteria from a hospital in recent 10 years. MethodsBacterial culture results of 60 846 clinical samples (blood, urine ,throat swab,sputum,stool , vagina swab,and sterile body fluid) from inpatients and outpatients between January,1999 and December,2008 were analysed retrospectively.ResultsThese isolates included 67 genus 207 species 18 674 strains of bacteria, the isolation rate was 30.69%(18 674/60 846), the ratio of gramnegative bacillus to grampositive coccus and fungus was 54.42∶32.21∶11.56. The major bacteria were Salmonella paratyhi A, Viridans streptococci, Escherichia coli, yeastlike fungi ,coagulase negative Staphylococcus and Staphylococcus aureus. The proportion of gramnegative bacillus rose obviously, so did the opportunistic pathogens. The isolation rates of Viridans streptococcus and enteric pathogens and Salmonella paratyhi A decreased (P<0.01). ConclusionChange in floral is in accordance with fundamental characteristics of presentday infection; The increase of opportunistic pathogens is disadvantageous to the prevention and treatment of multiple infectious diseases.
近一个世纪以来,抗菌药物在人类战胜各种感染性疾病的过程中发挥了关键作用,但日益突出的多重耐药菌问题已给临床抗感染治疗带来了严峻挑战。如何有效减缓多重耐药菌的产生,阻断多重耐药菌传播,已引起医学界、政府与社会的广泛关注。为加强多重耐药菌的医院感染管理,有效预防和控制多重耐药菌在医院内的产生和传播,保障患者的安全,由中国感染控制杂志组织,58位国内知名专家共同发起,邀请全国165位专家参与,历时10个月,召开了9场专题讨论会,在充分收集意见和讨论的基础上,最终形成了《多重耐药菌医院感染预防与控制中国专家共识》。共识荟萃了国内外多重耐药菌医院感染防控的最新进展,总结了我国大多数权威专家防控方面的宝贵经验,旨在规范和指导我国多重耐药菌医院感染的防控,提高我国多重耐药菌感染防控水平。
Objective To understand the colonization and resistance characteristics of multidrugresistant bacteria isolated from ICU patients. Methods Nasal vestibular and rectal swabs of 82 patients admitted in a hospital ICU from November, 2008 to April, 2009 were screened by bacteriological surveillance method, and antimicrobial susceptibility were performed. Data were analyzed by WHONET5.4 software. Results Multidrugresistant strains were detected among 38 patients , the colonization rate was 46.34%, which including 62 strains of extendedspectrum β lactamases (ESBLs) producing Enterobacteriaceae bacteria and 4 strains of methicillinresistant Staphylococcus aureus(MRSA), and multidrugresistant Acinetobacter baumannii and Pseudomonas aeruginosa was not detected. 62 strains of ESBLsproducing strains had lower drugresistant rates (4.84%) to imipenem and meropenem,but had high sensitive rates to the other antimicrobial agents, resistant rates varied with different bacteria; 4 MRSA strains were all sensitive to vancomycin, teicoplanin and linezolid, some were sensitive to clindamycin, fosfomycin and gentamicin, and all were resistant to other antimicrobials.Conclusion Colonization rate of multidrugresistant bacteria is high in patients in ICU, and drugresistance is serious, which should be paid attention by clinicians , surveillance should be intensified , so as to avoid the outbreak of multidrugresistant bacteria infection in hospital.
随着广谱抗菌药物及免疫抑制剂的使用,人口老龄化社会现象,抗菌药物耐药问题日益严重。和抗菌药物耐药相比,研制一种新型的抗菌药物的速度远远落后于前者。耐药的革兰阳性(G+)球菌是导致临床抗感染治疗失败的主要原因之一。达巴万星(dalbavancin)为Vicuron Pharmaceuticals公司开发的一种新型半合成糖肽类抗生素,为替考拉宁类似物A40926的衍生物,其化学结构式见图1。目前已完成了Ⅲ期临床试验,它对各类临床常见G+菌具有高度抗菌活性。达巴万星具有和替考拉宁相似的分子结构,但羧基肽基团末端的酰胺基修饰提高了达巴万星对葡萄球菌属,特别是凝固酶阴性葡萄球菌的抗菌活性;而亲脂支链和二聚体的形成提高了达巴万星的组织穿透性和与细菌细胞膜的亲和力。和替考拉宁等糖肽类抗生素一样,达巴万星通过与细菌细胞壁肽聚糖上D丙氨酰丙氨酸末端特异性结合,抑制细菌细胞壁肽聚糖的延伸和交联,阻止细胞壁合成而发挥杀菌作用。
ObjectiveTo explore the risk factors for nosocomial infection (NI)of Acinetobacter baummanii (A. baumannii) in patients in the internal medicine intensive care units (ICUs).MethodsA 1:2 matched casecontrol study was carried out in ICUs in a hospital between January 1,2007 and December 31,2008. Cases were patients with A. baumannii infections and controls were those without NI. Conditional Logistic regression analysis was performed to identify independent risk factors.ResultsThe independent risk factors were the number of the underlying diseases(OR=4.03), duration of nasal feeding tube(OR=11.37), using respirators(OR=9.83)and acute physiology and chronic health evaluation Ⅱ score system(OR=1.20); the protective factor was using vitamin(OR=0.05).ConclusionImproving patients’ body state and immunity and reducing invasive procedures are helpful for the control and prevention of NI with A. baumannii in patients in ICUs.
[Key words]intensive care unit;Acinetobacter baumannii;nosocomial infection;risk factors;casecontrol study
To investigate the change in drugresistance of Pseudomonas aeruginosa (P. aeruginosa) to βlactam antibiotics in a hospital, so as to provide reference for treatment of P. aeruginosa infection.MethodsDrug sensitivity tests of 2 127 strains of P. aeruginosa isolated fom clinic between 1999—2007 to 18 kinds of antibiotics were analysed.ResultsResistance of P. aeruginosa to 18 kinds of βlactam antibiotics increased year by year during the past 9 years, there was significant difference between each year (P<0.05 or P<0.01). The total resistant rates to meropenem, imipenem and ceftazidime were below 30%. ConclusionP. aeruginosa was resistant to many kinds of βlactam antibiotics, and resistant rate increased year by year, in order to control and slow down the emergence of the resistant strains , the use of third generation cephalosporins and carbapenems should be properly controlled .
To evaluate in vitro activity of linezolid and other antimicrobial agents against Enterococci spp. isolated from clinic.MethodsIdentification and antimicrobial sensitivity test of Enterococci spp. was carried out by Microscan WalkAway40 system.ResultsNo linezolidresistant strain was detected in 117 Enterococci spp. strains. Resistant rate of Enterococcus faecium and Enterococcus faecalis against vancomycin was 4.41% and 5.71% respectively, the resistant rates to penicillin, ampicillin, erythromycin, high concentration gentamycin, levofloxacin and ciprofloxacin were all above 70%.ConclusionLinezolid has high activity against Enterococci spp., especially the control of infections caused by multidrugresistant isolates.
ObjectiveTo realize the status and causes of catheterassociated nosocomial infection (CANI) in surgical intensive care unit (SICU) , so as to decrease the incidence by taking proper measures.MethodsSix hundred and fifteen patients with catheters in SICU between 2005 and 2009 were monitored prospectively, including the occurrence of CANI, patients’ age, length of hospital stay, invasive procedures, and pathogens.ResultsOne hundred and ninetyseven of 615 patients (32.03%) developed CANI, and CANI rate was 2.60%,12.85% and 56.40% in patients with 1 kind , 2 or 3 kinds of catheters simultaneously respectively, there were significant difference among three groups (χ2=151.55,P<0.001). The rate of ventilatorassociated pneumonia (VAP), catheterassociated urinary tract infection (CAUTI) , and central venous catheter (CVC)associated bloodstream infection (CVCBSI) per 1 000 catheter days was 15.51, 13.70 and 5.79 respectively. The average catheter utilization days before the occurrence of CANI were as follows: ventilator (12.22±11.29) days, urinary catheter (13.09±13.29) days , CVC (20.64±18.39) days respectively. The major pathogen in VAP , CAUTI and CVCBSI was Acinetobacter spp.(18.80%), Candida albicans (36.46%) and Acinetobacter spp.(18.75%) respectively.ConclusionPatients with more catheters , long hospital stay and long duration of catheters are prone to develop nosocomial infection . The key to the prevention of emerging of drugresistant strain and decrease in NI are strengthening of disinfection and isolation, shortening the time of catheter retaining, implementing hand hygiene, and using antimicrobial drug rationally.
目的调查某院消毒灭菌效果与环境卫生学监测情况。方法回顾性分析该院1997—2008年间消毒灭菌及环境卫生学监测资料。结果12年共采集48 497份样本,合格39 161份,合格率80.75%。样本量与其合格率整体呈上升趋势,空气合格率由60.04%升至97.91%;物体表面合格率由85.65%升至98.70%;医务人员手采样合格率由78.75%升至99.62%;使用中消毒液合格率由88.92%升至98.83%;紫外线灯合格率由77.62%升至97.13%;消毒灭菌物品合格率由97.27%升至100.00%(均P<0.01)。压力蒸汽灭菌器、污水处理在每年的监测中,合格率均为100.00%。结论该院消毒灭菌工作质量及环境卫生质量得到不断提高。
ObjectiveTo analyze the clinical characteristics and drug resistance of Acinetobacter baumannii (A.baumannii) pulmonary infection. MethodsClinical data of 65 cases of A.baumannii pulmonary infections in a hospital from June, 2006 to June, 2008 were analyzed.ResultsThe incidence rate of A.baumannii infections were high in general intensive care unit (ICU, 41.54%), neurological ICU (29.23%), neurosurgical ICU (10.77%), and respiratory department(10.77%);Resistant rates to many kinds of antimicrobial agents were >70%.The infected patients were almost aged, with many underlying diseases, with long hospitalization time and various invasive treatment, as well as receiving at least 2 kinds of antimicrobial agents before developing infection; some patients complicated with infections caused by the other pathogens, most were Pseudomonas aeruginosa (34.55%) and Stenotrophomonas maltophilia(20.00%) infections. ConclusionPatients with A.baumannii infections are in serious condition, antimicrobial resistance is high, realization of the clinical characteristics, infection distribution and drug resistance pattern are important to prevent and treat infections .
To evaluate the clinical efficacy and safety of high dosage levofloxacin injection in the treatment of hospitalacquired pneumonia(HAP) in intensive care unit (ICU).MethodsEightyfour patients with HAP in ICU from September ,2007 to December, 2008 were randomly divided into high dosage (HD group, n=50 ) and routine dosage levofloxacin injection treated group (control group, n=34), HD and control group both received intravenous drip of levofloxacin 500mg, once per 16 hours and once per 24 hours respectively, therapeutic efficacy and adverse reactions in both groups were observed.ResultsThe total efficacy rate of HD and control group was 88.00% and 76.47% respectively, there was no significant difference between the two (χ2=1.94, P>0.05); The effective time were (4.18±2.62)d and (5.64±2.72)d, the course of treatment were (7.87±3.66)d and (9.64±3.52)d, bacterial eradication rate was 86.00% and 64.71%, respectively, there were significant difference between two groups (t=2.47, P<0.01; t=2.19, P<0.05; χ2=4.10, P<0.05); adverse reactions were observed in 12.00% and 8.82% of patients in two groups respectively, there was no statistical significance (χ2=0.01, P>0.05). ConclusionHigh dosage levofloxacin is effective and safe for HAP in patients in ICU, and can save time for saving life, maybe widespread used.
手术部位感染(surgical site infection, SSI)指无植入物手术后30天内、有植入物(如人工心脏瓣膜、人造血管、机械心脏、人工关节等)手术后1年内发生的与手术相关感染,包括浅表切口感染、深部切口感染以及器官/组织间隙感染;SSIs是手术患者常见的并发症,常可致病情复杂化,影响患者康复,增加死亡率,延长住院时间和增加医疗费用[1]。因此,深入了解SSIs的危险因素,逆转促进SSIs发生的病理生理条件,对降低SSIs发生率,保障手术患者顺利康复具有至关重要的意义。
realize the detection and drug resistance of nonfermentative bacteria from clinical samples between January and December, 2008, so as to provide evidence for rational use of antimicrobial agents in clinic. MethodsBacteria were identified by ATB identification system, antimicrobial susceptibility tests were performed by KirbyBauer method. Results215 strains of nonfermentative bacteria were isolated from 3 555 samples, the isolation rate was 6.05%, which accounting for 19.15% (215/1 123) of total isolated bacteria; the most common isolated bacteria was Pseudomonas aeruginosa, which accounting for 41.86% of total nonfermentative bacteria, the next was Acinetobacter baumannii and Burkholderia cepacia, the constitutional ratio was 29.30% and 16.74% respectively. The isolation rates of nonfermentative bacteria varied with different infection sites, the isolation rates were high in samples of sputum and throat swabs, and excretion of subcutaneous tissue, which was 15.32% and 9.17% respectively. Pseudomonas aeruginosa, Acinetobacter baumannii, Burkholderia cepacia and Stenotrophomona maltophilia were all had obvious drug resistance. ConclusionThe isolation rate of nonfermentative bacteria in clinical infected patients are high, and drugresistance is strong. In order to control nonfermentative bacteria infection and emergence of drug resistant strain, antimicrobial agents for treatment of infection should be chosen according to antimicrobial susceptibility test results.
ObjectiveTo get information about pathogenic distribution and bacterial resistance .MethodsData about bacteria isolated from inpatients who were hospitalized between January 1st, 2006 to December 31st, 2008 were collected and analysed with WHONET 5.4 software.Results5 697 pathogenic bacteria were isolated within 3 years, which included 3 627 (63.67%) gramnegative and 1 536(26.96%)grampositive strains. Escherichia coli (895 strains,15.71%), Pseudomonas aeruginosa (873 strains, 15.32%), Klebsiella pneumoniae (446 strains,7.83%), Acinetobacter baumannii(366 strains, 6.43%) were the most common gramnegative isolates; Staphylococcus aureus(648 strains,11.37%), Enterococcus spp.(373 strains, 6.55%), and coagulasenegative Staphylococcus(349 strains,6.13%) were the top three grampositive isolates. The prevalence of extended spectrum βlactamases ( ESBLs) producing bacteria, methicillinresistant Staphylococcus aureus (MRSA) and methicillinresistant coagulasenegative Staphylococcus(MRCNS) increased year by year. Bacteria were isolated from various specimens, the top three were sputum (45.97%), secretion (16.54%) and urine (10.65%). Resistant rates of Escherichia coli, Klebsiella pneumoniae to carbapenems were all 0.00%, but 23.85%~31.76% of Pseudomonas aeruginosa isolates were carbapenemsresistant. Less than 15.52% of the above four kinds of bacteria were resistant to cefoperazone/ sulbactam, but they were highly resistant to other antimicrobial agents; more than 70% of Escherichia coli were quinoloneresistant. No Staphylococcus were detected to be resistant to glycopeptides, such as vancomycin and linezoid , but the resistant rates to the other commonly used antimicrobial agents were relatively high, more than 78.57% Staphylococcus were clindamycinresistant. ConclusionPathogenic bacteria are mainly isolated from sputum, secretion and urine, the main pathogens are gramnegative bacteria; Antimicrobial resistance is very severe in hospitalized patients. Surveillance of antimicrobial resistance is important and valuable for rational antimicrobial therapy.
ObjectiveTo understand the pathogenic characteristics and drug sensitivity of 8 strains of Neisseria meningitidis isolated in Hunan province between 2007—2008.MethodsNeisseria meningitidis strains were identified and clustered by serology and PCR test, drug sensitivity test was carried by minimum inhibitory concentration (MIC) agar dilution method.ResultsAmong 8 strains of Neisseria meningitidis, 5 strains were in serogroup C, 1 in serogroup B, 1 in serogroup Y and 1 was unidentified. All 8 strains were sensitive to penicillin, ampicillin, minocycline, ceftriaxone, cefotaxime, meropenem, rifampicin, but resistant to sulfamethoxazole/trimethoprim, 4 strains were resistant to ciprofloxacin and levofloxacin respectively, and 1 strain was resistant to chloramphenicol and azithromycin respectively.ConclusionEight epidemic strains of Neisseria meningitidis are mainly in serogroup C; penicillin, ceftriaxone, cefotaxime and meropenem should be used as the firstline drugs for the treatment of epidemic cerebrospinal meningitis, the resistance to quinolones and macrolides should be paid attention.
ObjectiveTo explore the risk factors for nosocomial methicillinresistant Staphylococcus aureus (MRSA) infection, so as to provide a scientific basis for taking effective measures to reduce nosocomial MRSA infection rates.Methods1:1 casecontrol study was performed, 108 pairs of research subjects were included in the research. Questionnaires were designed to study the history of case and control data. Multivariate nonconditional Logistic regression and chisquare test were used to analyze the data.ResultsAnalysis showed that the following factors were associated with nosocomial MRSA infection: old age (≥ 65 years old, P= 0.013), length of stay in hospital (P<0.001), the types of underlying disease (P<0.001), the number of invasive procedures (P<0.001), broadspectrum antimicrobial use(P<0.001), types of antimicrobial agents (P= 0.004) and duration use of antimicrobial agents (P<0.001). Multivariate analysis showed that the main risk factors related to nosocomial MRSA infection included length of stay in hospital (P<0.001), the number of invasive procedures (P= 0.001), types of used antimicrobial (P= 0.001) and duration use of antimicrobials (P<0.001).Conclusion Risk factors for nosocomial MRSA infections are long length of stay in hospital , frequent invasive operations , and longterm as well as multiple use of broadspectrum antimicrobial agents.
To explore the effective intervention measures to raise the curative effect of bacterial infections by promoting the pathogenic detection.MethodsPathogenic delivering rates, curative or improving rates, and average hospitalization days before and after performing intervention measures on pathogenic detection were compared and analysed.ResultsThe rate of sample delivering, positive rates, and the coincident rate of positive results and clinical manifestations increased from 44.23%, 43.48% and 72.50% before interposing to 58.82%, 55.79% and 89.74% after interposing respectively, the curative or improving rate increased form 93.27% to 97.48%, and the average hospitalization days shortened from 9.94d to 8.97d.ConclusionScientific and effective administrative and technical intervention measures is help for raising pathogenic delivering rate, promoting curative effect of antiinfection and shortening hospitalization days.
Objective To realize the incidence of surgical site infection (SSI) monitored with different methods, so as to provide reference for reducing infection rate and making infection control measures. Methods SSI occurred in patients with gastrointestinal tract operation in a hospital between July, 2007 (before performing targeted monitor, control group) and June, 2008 (after performing targeted monitor, monitored group)was compared. Results SSI in control and monitored group was 12.30% and 7.00% respectively, there was significant difference between two groups( χ2=3.98, P<0.05). Conclusion Targeted monitor can effectively reduce nosocomial infection rate.
Chin J Infect Control ® 2024 All Rights Reserved Supported by:Beijing E-Tiller Technology Development Co., Ltd. 湘ICP备17021739号-2